Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
1d
What's Next For Johnson & Johnson Stock?
Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.
1d
Johnson & Johnson Q3 Earnings Review: Nicely Poised For Steady Growth (Upgrade)
Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...
2d
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Judge unseals new evidence
Preliminary cause of death
School shooting report
PG&E shuts off power
La Nina could arrive soon
Republicans appeal ruling
NYC giant pigeon sculpture
Fire prompts evacuations
Three Americans detained
OK classroom Bible suit
Calif. oil refinery closure
Lebanese citizens get TPS
Teen tobacco use falls
NK sending troops to RU?
To furlough 700 workers
Eases voting rules
Nevada US Senate debate
At decade-high level
‘Full Self-Driving’ probe
Sued for alleged misconduct
FAA opens new safety review
$4M LAPD fentanyl seizure
Dow closes at record high
988 Lifeline georouting
Afghan man denied release
School shooting indictment
Emergency abortion ruling
Sells for $9M at auction
US charges ex-Indian spy
Space export curbs eased
Related topics
Q3
Republican Party
Medtech
Pittsburgh Pirates
Springfield
Feedback